TRIUMPH Observational Study
Not Applicable
- Conditions
- Patients with HER2 positive mCRC
- Registration Number
- JPRN-jRCT1030220064
- Lead Sponsor
- akamura Yoshiaki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
All patients who participated in the TRIUMPH study
Exclusion Criteria
Patients withdrawing consent for the TRIUMPH trial as of the end of April 2022
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival
- Secondary Outcome Measures
Name Time Method Progression-free survival<br>Duration of response<br>Time to treatment failure